跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-MOXIFLOXACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-MOXIFLOXACIN
Authorized
STANDARD
AG-MOXIFLOXACIN
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
92bd08d7b6111df6
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
92bd08d7b6111df6
Drug Approval Canada Name
AG-MOXIFLOXACIN
Product Name
AG-MOXIFLOXACIN
Status
Marketed
Status Date
2020-07-09
Original Market Date
2020-07-09
Din
02484757
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:04.04
Atc Original
S01AE07 MOXIFLOXACIN
Atc Name
s 01 ae 07
Aig Number
0142242003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)
0.5 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
92bd08d7b6111df6
Type
Standard
Back to Health Canada Approvals